Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.46 |
| ▸ | CA4 known ✓ | P22748 | 1/20 | 0.46 |
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | CNR2 | P34972 | 2/20 | 0.47 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.47 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.47 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.47 |
| ▸ | WNT3A | P56704 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium Ion SCHEMBL29208532 | 0.96 | LMNA (0.58) | LMNAGAAKDM4EALDH1A1HPGD | |
| Zinc Ion SCHEMBL9460998 | 0.96 | LMNA (0.58) | LMNAGAAKDM4EALDH1A1HPGD | |
| Silver SCHEMBL4964258 | 0.96 | LMNA (0.58) | LMNAGAAKDM4EALDH1A1HPGD | |
| SCHEMBL4961644 | 0.86 | LMNA (0.49) | LMNAGAACNR2KCNK3KCNK9 | |
| SCHEMBL746794 | 0.80 | LMNA (0.64) | LMNAGAACNR2KCNK3KCNK9 | |
| SCHEMBL28634751 | 0.80 | LMNA (0.64) | LMNAGAACNR2KCNK3KCNK9 | |
| Tetrabuthylammonium SCHEMBL23522678 | 0.79 | LMNA (0.43) | LMNAGAACNR2CTNNB1WNT3A | |
| SCHEMBL689420 | 0.79 | ALDH1A1 (0.52) | LMNAGAAKDM4EALDH1A1HPGD | |
| SCHEMBL19516460 | 0.79 | LMNA (0.44) | LMNAGAAKDM4EALDH1A1HPGD | |
| SCHEMBL27142668 | 0.79 | LMNA (0.44) | LMNAGAAKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102304714-A | Aluminum film-containing etching solution for liquid crystal display screen | MIANYANG ISAACS ELECTRONIC MATERIALS CO LTD | 2012-01-04 | — | — | CN | claimed |
| US-12509987-B2 | Continuous characterization and communication of chemical tracer | Patina IP LLC (US) | 2025-12-30 | — | — | US | disclosed |
| WO-2024258899-A1 | DIAGNOSTIC PLATFORM DIRECTLY CONNECTED TO A SUBTERRANEAN FORMATION | Patina IP LLC (US) | 2024-12-19 | — | — | WO | disclosed |
| WO-2024058815-A1 | CONTINUOUS CHARACTERIZATION AND COMMUNICATION OF CHEMICAL TRACER | Patina IP LLC (US) | 2024-03-21 | — | — | WO | disclosed |
| US-20230296018-A1 | CONTINUOUS CHARACTERIZATION AND COMMUNICATION OF CHEMICAL TRACER | Patina LLC (US) | 2023-09-21 | — | — | US | disclosed |
| CN-107311461-A | A kind of AMOLED display screens etching solution and preparation method thereof | 合肥市惠科精密模具有限公司 | 2017-11-03 | — | — | CN | disclosed |
| CN-102304714-A | Aluminum film-containing etching solution for liquid crystal display screen | MIANYANG ISAACS ELECTRONIC MATERIALS CO LTD | 2012-01-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509987-B2 | Continuous characterization and communication of chemical tracer | EXOSC10, CD69, FABP3 | CA2 114/4885CA4 376/4885PTGS1 3621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.